But brand managers who are relying solely on traditional ad placement methods rather than using newer, more sophisticated methodologies, may be missing opportunities to reach target patients as well as wasting spend.
So what are these new methods? Digital capabilities that anonymously link what we tune in to watch on TV with the prescription behavior of consumers. The result? An ability to determine the most effective networks, programs, and times of day to reach patients of interest and to measure the impact of the campaigns. In turn, it enables brand mangers to base the placement, measurement, and refinement of their strategies on empirical data, which can result in more efficient investments and greater accountability.Is Pre-Market Planning Hitting the Mark?
Given the significant investment that goes into pre-market campaign planning, particularly creative and message testing, the same level of rigor needs to be applied to ensure the ad is effectively reaching the intended audience of patients. However, TV real estate continues to be purchased based on traditional parameters of audience age and gender demographics, at the right price.
More Sophisticated Post-Market Methods
How exactly do these new methodologies work? Anonymous longitudinal patient data tracks, among other things, prescription activity over time. By reviewing what drugs patients have filled recently, they can be classified as being treated for conditions in different therapeutic markets. A combination of tuning and prescription behavior then enables an analysis of what patients in different healthcare markets are watching.
In addition, evaluations can determine the influence an ad has had on patients who viewed it. Advertisers are then able to accurately gauge differences in the prescription behavior of patients exposed to an ad compared with nonviewers.